Altium Capital Management LP - EUCRATES BIOMEDICAL ACQU COR ownership

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRW and the CUSIP is G3141W122. A total of 18 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Altium Capital Management LP ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q1 2023$4,820
-35.0%
133,3330.0%0.00%
-25.0%
Q4 2022$7,413
+48.3%
133,3330.0%0.00%
+100.0%
Q3 2022$5,000
-44.4%
133,3330.0%0.00%
-50.0%
Q2 2022$9,000
-64.0%
133,3330.0%0.00%
-50.0%
Q1 2022$25,000
-67.5%
133,3330.0%0.01%
-61.9%
Q4 2021$77,000
-28.0%
133,3330.0%0.02%
-25.0%
Q3 2021$107,000
-23.0%
133,3330.0%0.03%
-12.5%
Q2 2021$139,000133,3330.03%
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q3 2021
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 66,666$651,0000.02%
Altium Capital Management LP 133,333$77,0000.02%
Granite Point Capital Management, L.P. 133,332$77,0000.01%
AQR Arbitrage LLC 45,832$447,0000.01%
Radcliffe Capital Management, L.P. 33,333$325,0000.01%
COWEN AND COMPANY, LLC 178,347$103,0000.01%
CVI Holdings, LLC 118,333$69,0000.01%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 333,333$193,0000.00%
KINGDON CAPITAL MANAGEMENT, L.L.C. 66,665$36,0000.00%
683 Capital Management, LLC 200,000$116,0000.00%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders